Federal Register / Vol. 80, No. 77 / Wednesday, April 22, 2015 / Notices 22561 

Controlled substance Schedule 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Oxymorphone (9652) ................... II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

the listed controlled substances in bulk 

for sale to its customers. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09326 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Stepan Company 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic class, and applicants 

therefore, may file written comments on 

or objections to the issuance of the 

proposed registration in accordance 

with 21 CFR 1301.34(a) on or before 

May 22, 2015. Such persons may also 

file a written request for a hearing on 

the application pursuant to 21 CFR 

1301.43 on or before May 22, 2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. Comments 

and request for hearings on applications 

to import narcotic raw material are not 

appropriate. 72 FR 3417 (January 25, 

2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

of the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

February 9, 2015, Stepan Company, 

Natural Products Dept., 100 W. Hunter 

Avenue, Maywood, New Jersey 07607 

applied to be registered as an importer 

of coca leaves (9040), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import the 

listed controlled substance to 

manufacture bulk controlled substances 

for distribution to its customers. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09342 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Siegfried USA, LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before May 22, 2015. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before May 22, 

2015. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODXL, 8701 

Morrissette Drive, Springfield, Virginia 

22152. Request for hearings should be 

sent to: Drug Enforcement 

Administration, Attention: Hearing 

Clerk/LJ, 8701 Morrissette Drive, 

Springfield, Virginia 22152. Comments 

and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Deputy Assistant 

Administrator of the DEA Office of 

Diversion Control (‘‘Deputy Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

November 17, 2014, Siegfried USA, 

LLC, 33 Industrial Park Road, 

Pennsville, New Jersey 08070 applied to 

be registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled substance Schedule 

Opium, raw (9600) ....................... II 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

listed controlled substances to bulk 

manufacture API’s for distribution to its 

customer. 

Dated: April 14, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–09336 Filed 4–21–15; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration: Actavis Pharma, Inc. 

ACTION: Notice of registration. 

SUMMARY: Actavis Pharma, Inc. applied 

to be registered as an importer of certain 

basic classes of controlled substances. 

The Drug Enforcement Administration 

(DEA) grants Actavis Pharma, Inc., 

registration as an importer of those 

controlled substances. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 4, 2014, FR 

79 32315, Actavis Pharma, Inc., 2455 

Wardlow Road, Corona, California 


asabaliauskas on DSK5VPTVN1PROD with NOTICES